Published: 2016-12-27

Coronary arteries bypass grafting in dialysis dependent end stage renal disease, results and outcome

Haitham Altaani, Safwan Alfawares, Saker Alsharoo, Mahmoud Obeidate, Khaled Maloof, Saad Jabber


Background: The objective is to assess the results and outcome of patients with dialysis dependent end stage renal failure who underwent coronary artery bypass grafting.

Methods: In this retrospective study we analyzed the medical records of dialysis dependent end stage renal failure patients who underwent isolated coronary artery bypass grafting from January 2008 till December 2012 at queen alia heart institute. The total number of patients were 62 out of 6522 (0.95%). 42 of them were male (68%), the average age was 48±12 year, the duration of dialysis was 17±7 months. The medical profile of the patients, renal condition and duration of dialysis were analyzed. Preoperative cardiac condition and risk factors were also analyzed. Operative variables and postoperative results including mortality and post-operative renal and cardiac related complications were also analyzed.

Results: Total in hospital mortality was 5 (8%), the cause of mortality was renal failure related causes in 2 patients, sepsis in 2 patients, cardiac causes in one patient. Average time for extubation, ICU stay and hospital stay was 9±2.3 hours, 27±7 hours and 7 days respectively. The average amount of blood loss postoperatively was 450±55 ml; five patients (8%) were resent to the operating theatre for exploration resternotomy because of bleeding. The average creatinine level 6.5±1.5 mg/dl. Six patients need dialysis in the first 24 hours of the operation (9.7%), most patients were returned to the usual protocol of dialysis, which was in average of 3 times per week.

Conclusions: Coronary artery bypass grafting is the standard treatment in patient of end stage renal disease with coronary artery disease. Surgery is the ideal treatment in three vessel and left main disease according to SYNTAX trial. Those patients are high risk candidate for surgery, but proper preoperative, intraoperative and postoperative management decrease the risk and make the procedure safe.



Kidney, Coronary artery bypass grafting, Heart failure

Full Text:



Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL. American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050-65.

Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in haemodialysis and peritoneal dialysis. Kidney Int. 2004;66(6):2389-401.

Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant. 1997;12:718-23.

Edwards NC, Steeds RP, Ferro CJ, Townend JN. The treatment of coronary artery disease in patients with chronic kidney disease. 2006;QJM99:723-36.

Rodriguez A, Alemparte MR, Baldi J, Navia J, Delacasa A et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: Results from the ERACI II study. Heart. 2003;89:184-8.

Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207-11.

Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation. 2004;110:1890-5.

O’Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT et al. Multivariate prediction of in-hospital mortality associated with coronary bypass surgery. Circulation. 1992;85:2110-8.

Peper WA, Taylor PC, Paganini EP, Svensson LG, Ghattas MA, Loop FD. Mortality and results after cardiac surgery in patients with end-stage renal disease. Cleve Clin J Med. 1988;55:63-7.

Koyanagi T, Nishida H, Endo M et al. Coronary artery bypass grafting in chronic renal dialysis patients: intensive perioperative dialysis and extensive usage of arterial grafts. Eur J Cardiothorac Surg. 1994;8:505-7.

DeFoe G, Ross C, Olmstead E, et al. Low hematocrit on bypass pump and adverse outcomes during coronary artery bypass surgery. Circulation. 1998;98(suppl I):I-613.

Liu JY, Birkmeyer NJ, Sanders JH, Morton JR, Henriques HF, Lahey SJ, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 2000;102(24):2973-7.

Wanner C, Jager KJ. Cardiovascular disease: Is CABG really better than PCI in dialysis patients? Nat Rev Nephrol. 2013;9(4):197-8.